Skip to main content
Clinical Trials/CTRI/2023/01/049236
CTRI/2023/01/049236CompletedPhase 4

Comparison of intravenous Magnesium-Lignocaine or Magnesium-Lignocaine-Ketorolac versus normal saline for perioperative pain in laparoscopic cholecystectomy

Department of Anaesthesia and Intensive care0 sites120 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Body mass index (BMI): 18-35 kg.m-2
  • 2. Patients having American Society of Anaesthesiologists (ASA) Grade I-II
  • 3. Patients scheduled to undergo laparoscopic cholecystectomy

Exclusion Criteria

  • 1. Cardiac conduction abnormalities and congestive heart failure
  • 2. Renal or hepatic impairment
  • 3. Neurological disorders
  • 4. Pregnant and lactating women
  • 5. Patients not able to understand VAS
  • 6. History of substance abuse
  • 7. Contraindications to study drugs: lignocaine, ketorolac, magnesium
  • 8. Chronic pain conditions, neurodegenerative or autoimmune disorders

Investigators

Sponsor
Department of Anaesthesia and Intensive care

Similar Trials